Lauris et al v. Novartis AG et al

Filing 51

ORDER Adopting 48 FINDINGS AND RECOMMENDATIONS signed by Chief Judge Lawrence J. O'Neill on 8/9/2016. (Sant Agata, S)

1
2
3
4
5
6
7
8

UNITED STATES DISTRICT COURT

9

EASTERN DISTRICT OF CALIFORNIA

10
11

KRISTI LAURIS, et. al.,

12

Plaintiffs,

13

Case No. 1:16-cv-00393-LJO-SAB
ORDER ADOPTING FINDINGS AND
RECOMMENDATIONS

v.
(ECF Nos. 33-35, 44, 45, 48)

14
15

NOVARTIS AG, et al.,
Defendants.

16
17

The complaint in this action was filed on March 22, 2016. On June 20, 2016, Defendant

18 Novartis Pharmaceuticals Corporation (“NPC”) filed a motion to dismiss in which Defendant
19 Novartis AG joined. The motion was referred to the undersigned for issuance of findings and
20 recommendations pursuant to 28 U.S.C. § 636(b)(1)(B) and Local Rule 302.
21

On March 14, 2014, the magistrate judge filed a findings and recommendations. The

22 findings and recommendations recommended denying Defendants’ motion to dismiss. The
23 findings and recommendations was served on the parties and contained notice that any objections
24 to were to be filed within fourteen days (14) days from the date of service. The period for filing
25 objections has passed and no objections have been filed.
26

In accordance with the provisions of 28 U.S.C. § 636(b)(1)(C), this Court has conducted

27 a de novo review of this case. Having carefully reviewed the entire file, the Court finds the
28 findings and recommendations to be supported by the record and by proper analysis.

1

1

Accordingly, IT IS HEREBY ORDERED that:

2

1.

and

3
4

The findings and recommendations, filed July 22, 2016, is ADOPTED IN FULL;

2.

Defendants Novartis Pharmaceutical Corporation and Novartis AG’s motion to
dismiss is DENIED.

5
6
7
8

IT IS SO ORDERED.
Dated:

/s/ Lawrence J. O’Neill _____

August 9, 2016

UNITED STATES CHIEF DISTRICT JUDGE
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

2